Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Study of Efficacy and Safety of Long-acting Low Dose Ropeginterferon in Patients With Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis: a Randomized Prospective Trial

NCT03831776 is registered in ClinicalTrials.gov with St. Olavs Hospital as lead sponsor.

NCT NCT03831776
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03831776 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Study of Efficacy and Safety of Long-acting Low Dose Ropeginterferon in Patients With Chronic Myeloid Leukemia Treated With Bosutinib From Diagnosis: a Randomized Prospective Trial
Lead sponsor
St. Olavs Hospital
Phase
Phase 2
Overall status
Completed
Start date
March 25, 2019
Completion date
December 31, 2024
Enrollment
212 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

chronic myeloid leukemia